Goldman Sachs Group Inc Teva Pharmaceutical Industries LTD Put Options Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 13, 2024	SELL	$8.12 - $10.63 $3.65 Million - $4.78 Million	-450,000 Reduced 34.68%	847,400 $8.85 Million
Q3 2023 May 14, 2024	BUY	$7.48 - $10.7 $3.37 Million - $4.82 Million	450,000 Added 53.1%	1,297,400 $13.2 Million
Q1 2023 May 14, 2024	SELL	$8.36 - $11.37 $1.99 Million - $2.71 Million	-238,500 Reduced 15.53%	1,297,400 $11.5 Million
Q1 2023 May 11, 2023	SELL	$8.36 - $11.37 $1.99 Million - $2.71 Million	-238,500 Reduced 15.53%	1,297,400 $11.5 Million
Q2 2022 May 14, 2024	BUY	$7.38 - $10.4 $5.08 Million - $7.16 Million	688,500 Added 81.25%	1,535,900 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $10.9 Million - $14.1 Million	1,380,900 Added 890.9%	1,535,900 $12.3 Million
Q3 2021 Nov 10, 2021	BUY	$8.38 - $10.18 $1.3 Million - $1.58 Million	155,000 New	155,000 $1.51 Million

603

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.